IDEAYA Biosciences, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (8)

View All

Latest Posts

About This Stock More About This Stock
Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine
Article By: Jim Van Meerten
Thursday, January 11, 2024 11:00 AM EDT
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
In this article: IDYA
Read
Buy/Sell: Wall Street's Top 5 Stock Calls This Week - Sunday, Jan. 1
Article By: The Fly
Sunday, January 1, 2023 12:59 PM EDT
What was Wall Street buzzing about this past week? Let's take a closer look at the top 5 buy calls made by Wall Street’s best analysts during the week of Dec. 26-30, 2022.
In this article: GNRC, FOUR, NFLX, SWKH, IDYA
Read
The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance
Article By: Benzinga
Friday, November 1, 2019 7:38 AM EDT
Here's a roundup of top developments in the biotech space over the last 24 hours.
In this article: AMGN, BGNE, MNK, PRTK, IDYA, CDNA, BLUE Also: HOTH, AGN, AZN, BMY, GSK, RMD, ACOR, ACRX, ALIM, AMAG, BCRX, CERS, IMGN, NURO, RMTI, CELG, VRTX, ABBV, AGIO, REPH, RETA, PRTO, MGNX, OPGN, MGEN, DOVA, DRNA, DCPH, TRVI, OYST, RAPT, ARDS, MIRM, ITRM, COCP, CYCN, GMAB
Read
All Posts

Latest Tweets for $IDYA

No tweets yet!

PARTNER HEADLINES